BamSEC and AlphaSense Join Forces
Learn More

Cellectar Biosciences Inc. – Underwriting Agreements

NASDAQ: CLRB    
Share price (3/24/26): $3.01    
Market cap (3/24/26): $12.8 million
Search in Documents
Key Exhibits
External Links

Underwriting Agreements Filter

EX-1
from SCHEDULE 13G 1 page Exhibit 1 Joint Filing Agreement Pursuant to Rule 13d-1
12/34/56
EX-1
from SCHEDULE 13G 1 page Joint Filing Agreement
12/34/56
EX-1.1
from S-1 52 pages [ ] Shares of Common Stock, [ ] Pre-Funded Warrants Exercisable Into [___] Shares of Common Stock and [ ] Common Warrants Exercisable Into [___] Shares of Common Stock Cellectar Biosciences, Inc. Underwriting Agreement
12/34/56
EX-1.2
from S-3 46 pages Cellectar Biosciences, Inc. Equity Distribution Agreement
12/34/56
EX-1.1
from 8-K 17 pages Placement Agency Agreement October 20, 2022
12/34/56
EX-1.1
from 8-K 36 pages 18,148,136 Shares of Common Stock Cellectar Biosciences, Inc. Underwriting Agreement
12/34/56
EX-1.1
from S-1/A 39 pages Shares of Common Stock, Pre-Funded Warrants, and Series H Warrants Cellectar Biosciences, Inc. Underwriting Agreement
12/34/56
EX-1.1
from 8-K 16 pages Placement Agency Agreement
12/34/56
EX-1.1
from S-1/A 41 pages Shares of Common Stock, Shares of Series C Convertible Preferred Stock (Convertible Into Shares of Common Stock), and Warrants (Exercisable for Shares) Cellectar Biosciences, Inc. Underwriting Agreement
12/34/56
EX-1.1
from 8-K 17 pages Placement Agency Agreement
12/34/56
EX-1.1
from S-1/A 39 pages Shares of Common Stock Shares of Series a Convertible Preferred Stock (Convertible Into Shares of Common Stock) and Series C Warrants (Exercisable for Shares) Cellectar Biosciences, Inc. Underwriting Agreement
12/34/56
EX-1
from SC 13D 19 pages Series A-2016 Common Stock Purchase Warrant Cellectar Biosciences, Inc
12/34/56
EX-1.1
from S-1/A 39 pages Shares of Common Stock Pre-Funded Warrants and Warrants (Exercisable for Shares) Cellectar Biosciences, Inc. Underwriting Agreement
12/34/56
EX-1.1
from 8-K 16 pages Placement Agency Agreement
12/34/56
EX-1
from SC 13G ~5 pages Joint Filing Agreement
12/34/56
EX-1.1
from S-1/A 56 pages Underwriting Agreement Between Cellectar Biosciences, Inc. and Aegis Capital Corp., as Representative of the Several Underwriters Cellectar Biosciences, Inc. Underwriting Agreement
12/34/56
EX-1.1
from 8-K 34 pages Underwriting Agreement Between Novelos Therapeutics, Inc. and Rodman & Renshaw, LLC as Underwriter Novelos Therapeutics, Inc. Underwriting Agreement
12/34/56
EX-1.1
from S-1/A 34 pages Underwriting Agreement Between Novelos Therapeutics Inc. and Rodman & Renshaw, LLC as Underwriter 1 Novelos Therapeutics, Inc. Underwriting Agreement
12/34/56
EX-1
from 8-K 1 page Certificate of Incorporation
12/34/56